Virology And Bacteriology Market Report 2026

Virology And Bacteriology Market Overview

• Virology And Bacteriology market size has reached to $2.67 billion in 2025 • Expected to grow to $4.12 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Incidences Of Infectious Diseases Propel Growth In Virology And Bacteriology Market • Market Trend: Advancing Diagnostic Capabilities In Virology And Bacteriology Through Innovative Bacteria Detection Kits • North America was the largest region in 2025.

What Is Covered Under Virology And Bacteriology Market?

Virology and bacteriology refer to the scientific disciplines dedicated to studying viruses and bacteria, respectively. Virology studies viruses, including their structure, function, and the diseases they cause. Bacteriology deals with bacteria, examining their physiology, genetics, and role in health and disease. These fields are used to diagnose infections, develop vaccines and antibiotics, and advance knowledge about microbial life and its interactions with humans and other organisms. The main products of virology and bacteriology are equipment and reagents. Equipment in the virology and bacteriology market refers to the various instruments and machines used for the detection, analysis, and study of viruses and bacteria. This includes laboratory devices such as PCR machines, sequencers, microscopes, centrifuges, and incubators. The various technologies involved are molecular diagnostics, immunoassays, diagnostic imaging, and information technology and are used by several end users such as hospitals, diagnostic centers, research laboratories, and blood banks.

What Is The Virology And Bacteriology Market Growth Forecast?

The virology and bacteriology market size is expected to see strong growth in the next few years. It will grow to $4.12 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for rapid and point-of-care diagnostics, rising focus on antimicrobial resistance monitoring, expansion of genomic sequencing applications, growing investments in laboratory automation, increased emphasis on early disease detection. Major trends in the forecast period include increasing adoption of molecular diagnostic technologies, rising use of automated laboratory systems, growing focus on rapid pathogen detection, expansion of high-throughput testing capabilities, enhanced integration of laboratory information systems.

What Is The Driver Of The Virology And Bacteriology Market?

The rising incidences of infectious diseases are expected to propel the growth of the virology and bacteriology market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that invade and multiply within the body. Some of the contagious diseases include influenza, tuberculosis (TB), HIV/AIDS, malaria, and others. The increasing prevalence of infectious diseases is due to the growing challenges posed by pathogens, potentially due to globalization, urbanization, antimicrobial resistance, and environmental changes. Virology and bacteriology testing help diagnose infectious diseases by identifying the specific pathogens responsible for the illness, allowing for targeted treatment and management. For instance, in November 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported 9,633 tuberculosis (TB) cases in 2023, up 15.6% from 8,332 cases in 2022. Therefore, the rising incidence of infectious diseases will drive the virology and bacteriology industry.

Key Players In The Global Virology And Bacteriology Market

Major companies operating in the virology and bacteriology market are F. Hoffmann-La Roche AG, Merck KGaA, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Cepheid Inc., Eiken Chemical Co. Ltd., NEOGEN Corporation, Cerba Research, Luminex Corporation, Fujirebio Diagnostics Inc., Trinity Biotech plc, Microbiologics Inc., Bionano Genomics Inc., Scienion GmbH, Quidel Corporation

Global Virology And Bacteriology Market Trends and Insights

Major companies operating in the virology and bacteriology market are focused on developing innovative products, such as bacteria detection kits, to advance diagnostic capabilities and address the challenges of infectious diseases. Bacteria detection kits are diagnostic tools designed to identify and analyze the presence of bacteria in various samples, such as blood, urine, food, or environmental samples. For instance, in December 2023, HiMedia Laboratories LLC, an India-based bioscience company, partnered with NG Biotech, a France-based manufacturer of in vitro diagnostic tools, and launched the NG-Test CARBA 5 kits for detection of carbapenemase-producing bacteria, which were approved by the Central Drugs Standard Control Organization (CDSCO). These kits are equipped with advanced technology to accurately identify a broad spectrum of antimicrobial-resistant bacteria, including those that produce enzymes such as carbapenemases. The kits offer rapid and reliable results, facilitating prompt decision-making in clinical settings. They are designed to be user-friendly and compatible with various sample types, including blood, urine, and environmental samples.

What Are Latest Mergers And Acquisitions In The Virology And Bacteriology Market?

In October 2025, Virology Research Services Ltd., a UK-based provider of specialized virology contract research and diagnostic services, partnered with Advanced Virology Inc. With this partnership, the two firms aim to offer integrated end-to-end solutions from high-fidelity virus stock generation through custom assay development and QC testing, thereby streamlining workflows and accelerating development of vaccines, therapeutics, and diagnostics for viral pathogens. Advanced Virology Inc. is a U.S.-based company that produces custom virus stocks (wild type, reporter variants, inactivated preparations, and mutants) and supports research, development, and quality-controlled distribution of virus materials for R&D.

What Defines the Virology And Bacteriology Market?

The virology and bacteriology market consist of revenues earned by entities by clinical services, public health services, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The virology and bacteriology market also includes sales of laboratory equipment, vaccines, and therapeutic agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Virology And Bacteriology Market Report 2026?

The virology and bacteriology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the virology and bacteriology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.